AEMD Financials

Income Statement
MetricQ1 2027Q4 2026Q3 2026Q2 2026Q1 2026
Revenue
0
0
0
0
0
Cost of Revenue
0
0
0
0
0
Gross Profit
0
0
0
0
0
Operating Expenses
1.6M
-18.1%
1.9M
-6.4%
2.1M
+36.6%
1.5M
-15.8%
1.8M
R&D
0
0
0
0
0
SG&A
1.6M
-18.1%
1.9M
-6.4%
2.1M
+36.6%
1.5M
-15.8%
1.8M
Operating Income
-1579202
+18.1%
-1929296
+6.4%
-2062116
-36.6%
-1509830
+15.8%
-1792390
EBITDA
-1506342
+18.6%
-1849749
+6.6%
-1980513
-38.5%
-1429964
+16.4%
-1709753
Net Income
-1547912
+17.9%
-1884266
+6.6%
-2018245
-35.7%
-1487100
+15.6%
-1761858
EPS (Basic)
$-4.02
+38.8%
$-6.57
+46.4%
$-12.25
+34.5%
$-18.70
+55.9%
$-42.42
EPS (Diluted)
$-4.02
+38.8%
$-6.57
+46.4%
$-12.25
+34.5%
$-18.70
+55.9%
$-42.42
Shares (Diluted)
384.7K
+34.2%
286.7K
+74.2%
164.6K
+107.1%
79.5K
+91.4%
41.5K
AETHLON MEDICAL (AEMD) โ€” Financials